Country: New Zealand
Language: English
Source: Medsafe (Medicines Safety Authority)
Hydrocortisone butyrate 0.1%;
Link Pharmaceuticals Ltd
Hydrocortisone butyrate 0.1%
0.1 %
Topical ointment
Active: Hydrocortisone butyrate 0.1% Excipient: Liq. paraf. gel with 5% poyethylene oleogel to 100%.
Tube, aluminium, 1x15g, 15 g
Prescription
Prescription
NewChem SpA
Package - Contents - Shelf Life: Tube, aluminium, 1x15g - 15 g - 60 months from date of manufacture stored at or below 25°C - Tube, aluminium, 1x30g - 30 g - 60 months from date of manufacture stored at or below 25°C - Tube, aluminium, 1x100g - 100 g - 60 months from date of manufacture stored at or below 25°C
1974-10-10
1 CONSUMER MEDICINE INFORMATION LOCOID 0.1% HYDROCORTISONE BUTYRATE FORMULATIONS LIPOCREAM OINTMENT TOPICAL EMULSION (LOCOID CRELO ® ) SCALP LOTION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Locoid ® . It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you using this medicine against the expected benefits. Use Locoid ® as instructed. IF YOU HAVE ANY CONCERNS ABOUT USING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET. You may need to read it again. WHAT LOCOID ® IS USED FOR Locoid ® is used on the skin in adults and children to relieve the redness, swelling, itching and discomfort of skin inflammation such as: • Psoriasis (a skin disorder with raised, rough, reddened areas covered with dry, fine silvery scales) • Eczema (a skin condition with itching, redness and a burning feeling. In some forms of eczema there may be oozing sores that become hard and scaly) • Other types of dermatitis (itching skin diseases) Hydrocortisone butyrate belongs to a group of medicines called corticosteroids. Your doctor may have prescribed Locoid ® for another reason. Ask your doctor why this medicine has been prescribed for you. This medicine is available only with a doctor’s prescription. BEFORE YOU USE LOCOID ® _WHEN YOU MUST NOT USE LOCOID_ _®_ DO NOT USE THIS MEDICINE IF YOU HAVE: 1. AN ALLERGY TO: • any medicine containing hydrocortisone butyrate 2 • any of the ingredients listed at the end of this leaflet (see Product Description). Some of the symptoms of an allergic reaction may include shortness of breath, wheezing or difficulty breathing; swelling of the face, lips, tongue or other parts of the body; rash, itching or hives on the skin. 2. SKIN LESIONS CAUSED BY: • ANY BACTERIAL INFECTION (SUCH AS IMPETIGO, TUBERCULOSIS) • ANY VIRAL INFECTION (SUCH AS COLD SORES, SHINGLES, CHICKEN POX, COMMON WARTS, FLAT WARTS, Read the complete document
Page 1 of 5 NEW ZEALAND DATA SHEET 1 LOCOID ® Lipocream Ointment Topical Emulsion (Locoid Crelo ® ) Scalp Lotion hydrocortisone butyrate 2 QUALITATIVE AND QUANTITATIVE COMPOSTION Each formulation contains active ingredient 0.1% hydrocortisone butyrate. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM LIPOCREAM: white or nearly white cream OINTMENT: white ointment TOPICAL EMULSION (LOCOID CRELO ® ): a practically white emulsion SCALP LOTION: clear, colourless solution 4 CLINICAL PARTICULARS 4.1 INDICATIONS Corticosteroid for topical application in adults and children. The products are recommended for clinical use in the treatment of conditions responsive to topical corticosteroids, e.g. eczema, dermatitis and psoriasis. 4.2 DOSAGE AND METHOD OF ADMINISTRATION For adults and children, to be applied to the affected parts one to four times a day, or as directed by the physician. In a controlled trial, once daily administration was associated with a slower rate of skin clearance and may, therefore, be especially recommended in cases where considerations of convenience and/or compliance arise. Where necessary, application may be made under an occlusive dressing. 4.3 CONTRAINDICATIONS • Skin lesions caused by: − bacterial infections (e.g. pyodermias, luetic and tuberculous processes) − viral infections (e.g. varicellae, herpes simplex, herpes zoster, verrucae vulgares, verrucae planae, condylomata, mollusca contagiosa) − mycotic and yeast infections − parasitic infections (e.g. scabies) • Ulcerous skin lesions, wounds • Adverse reactions induced by corticosteroids (e.g. dermatitis perioralis, striae atrophicae) • Ichthyosis, juvenile dermatosis plantaris, acne vulgaris, acne rosacea, fragility of the skin vessels, skin atrophy Page 2 of 5 • Allergic hypersensitivity to components of the vehicle or to corticosteroids (the latter rarely occurs). 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE In pregnant animals, administration of corticosteroids can cause abnormalities of foetal d Read the complete document